Your browser doesn't support javascript.
loading
Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
Karamouzian, Mohammad; Dohoo, Carolyn; Forsting, Sara; McNeil, Ryan; Kerr, Thomas; Lysyshyn, Mark.
Afiliación
  • Karamouzian M; British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
  • Dohoo C; School of Population and Public Health, University of British Columbia, 5804 Fairview Avenue, Vancouver, BC, V6T 1Z3, Canada.
  • Forsting S; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616913555, Iran.
  • McNeil R; Public Health Agency of Canada, Ottawa, ON, K1A 0K9, Canada.
  • Kerr T; Vancouver Coastal Health Authority, Vancouver, BC, V5Z 4C2, Canada.
  • Lysyshyn M; British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.
Harm Reduct J ; 15(1): 46, 2018 09 10.
Article en En | MEDLINE | ID: mdl-30200991
ABSTRACT

BACKGROUND:

British Columbia, Canada, is experiencing a public health emergency related to opioid overdoses driven by consumption of street drugs contaminated with illicitly manufactured fentanyl. This cross-sectional study evaluates a drug checking intervention for the clients of a supervised injection facility (SIF) in Vancouver.

METHODS:

Insite is a facility offering supervised injection services in Vancouver's Downtown East Side, a community with high levels of injection drug use and associated harms, including overdose deaths. During July 7, 2016, to June 21, 2017, Insite clients were offered an opportunity to check their drugs for fentanyl using a test strip designed to test urine for fentanyl. Results of the drug check were recorded along with information including the substance checked, whether the client intended to dispose of the drug or reduce the dose and whether they experienced an overdose. Logistic regression models were constructed to assess the associations between drug checking results and dose reduction or drug disposal. Crude odds ratios (OR) and 95% confidence intervals (CI) were reported.

RESULTS:

About 1% of the visits to Insite during the study resulted in a drug check. Out of 1411 drug checks conducted by clients, 1121 (79.8%) were positive for fentanyl. Although most tests were conducted post-consumption, following a positive pre-consumption drug check, 36.3% (n = 142) of participants reported planning to reduce their drug dose while only 11.4% (n = 50) planned to dispose of their drug. While the odds of intended dose reduction among those with a positive drug check was significantly higher than those with a negative result (OR = 9.36; 95% CI 4.25-20.65), no association was observed between drug check results and intended drug disposal (OR = 1.60; 95% CI 0.79-3.26). Among all participants, intended dose reduction was associated with significantly lower odds of overdose (OR = 0.41; 95% CI 0.18-0.89).

CONCLUSIONS:

Although only a small proportion of visits resulted in a drug check, a high proportion (~ 80%) of the drugs checked were contaminated with fentanyl. Drug checking at harm reduction facilities such as SIFs might be a feasible intervention that could contribute to preventing overdoses in the context of the current overdose emergency.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fentanilo / Contaminación de Medicamentos / Analgésicos Opioides Tipo de estudio: Evaluation_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Harm Reduct J Año: 2018 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fentanilo / Contaminación de Medicamentos / Analgésicos Opioides Tipo de estudio: Evaluation_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Harm Reduct J Año: 2018 Tipo del documento: Article País de afiliación: Canadá